154 related articles for article (PubMed ID: 18425807)
1. Controlled release of repifermin from polyelectrolyte complexes stimulates endothelial cell proliferation.
Huang M; Berkland C
J Pharm Sci; 2009 Jan; 98(1):268-80. PubMed ID: 18425807
[TBL] [Abstract][Full Text] [Related]
2. Polyelectrolyte complexes stabilize and controllably release vascular endothelial growth factor.
Huang M; Vitharana SN; Peek LJ; Coop T; Berkland C
Biomacromolecules; 2007 May; 8(5):1607-14. PubMed ID: 17428030
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo effects of repifermin (keratinocyte growth factor-2, KGF-2) on human carcinoma cells.
Alderson R; Gohari-Fritsch S; Olsen H; Roschke V; Vance C; Connolly K
Cancer Chemother Pharmacol; 2002 Sep; 50(3):202-12. PubMed ID: 12203102
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of repifermin (keratinocyte growth factor-2) against abnormalities in gastrointestinal mucosal transport in a murine model of colitis.
Greenwood-Van Meerveld B; Venkova K; Connolly K
J Pharm Pharmacol; 2003 Jan; 55(1):67-75. PubMed ID: 12625869
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of topically applied repifermin (recombinant human keratinocyte growth factor-2) to accelerate wound healing in venous ulcers.
Robson MC; Phillips TJ; Falanga V; Odenheimer DJ; Parish LC; Jensen JL; Steed DL
Wound Repair Regen; 2001; 9(5):347-52. PubMed ID: 11896977
[TBL] [Abstract][Full Text] [Related]
6. Effect of polyanions on the structure and stability of repifermin (keratinocyte growth factor-2).
Derrick T; Grillo AO; Vitharana SN; Jones L; Rexroad J; Shah A; Perkins M; Spitznagel TM; Middaugh CR
J Pharm Sci; 2007 Apr; 96(4):761-76. PubMed ID: 17094125
[TBL] [Abstract][Full Text] [Related]
7. Noncovalent PEGylation by polyanion complexation as a means to stabilize keratinocyte growth factor-2 (KGF-2).
Khondee S; Olsen CM; Zeng Y; Middaugh CR; Berkland C
Biomacromolecules; 2011 Nov; 12(11):3880-94. PubMed ID: 21954860
[TBL] [Abstract][Full Text] [Related]
8. Repifermin (keratinocyte growth factor-2) reduces the severity of graft-versus-host disease while preserving a graft-versus-leukemia effect.
Clouthier SG; Cooke KR; Teshima T; Lowler KP; Liu C; Connolly K; Ferrara JL
Biol Blood Marrow Transplant; 2003 Sep; 9(9):592-603. PubMed ID: 14506661
[TBL] [Abstract][Full Text] [Related]
9. Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial.
Sandborn WJ; Sands BE; Wolf DC; Valentine JF; Safdi M; Katz S; Isaacs KL; Wruble LD; Katz J; Present DH; Loftus EV; Graeme-Cook F; Odenheimer DJ; Hanauer SB
Aliment Pharmacol Ther; 2003 Jun; 17(11):1355-64. PubMed ID: 12786629
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic and pharmacokinetic profile of repifermin (KGF-2) in monkeys and comparative pharmacokinetics in humans.
Sung C; Parry TJ; Riccobene TA; Mahoney A; Roschke V; Murray J; Gu ML; Glenn JK; Caputo F; Farman C; Odenheimer DJ
AAPS PharmSci; 2002; 4(2):E8. PubMed ID: 12102617
[TBL] [Abstract][Full Text] [Related]
11. Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation.
Freytes CO; Ratanatharathorn V; Taylor C; Abboud C; Chesser N; Restrepo A; Arango J; Odenheimer D
Clin Cancer Res; 2004 Dec; 10(24):8318-24. PubMed ID: 15623608
[TBL] [Abstract][Full Text] [Related]
12. Morphological and growth responses of vascular smooth muscle and endothelial cells cultured on immobilized heparin and dextran sulfate surfaces.
Robu IS; Walters HL; Matthew HWT
J Biomed Mater Res A; 2017 Jun; 105(6):1725-1735. PubMed ID: 28198136
[TBL] [Abstract][Full Text] [Related]
13. Adhesion, proliferation, and gene expression profile of human umbilical vein endothelial cells cultured on bilayered polyelectrolyte coatings composed of glycosaminoglycans.
Heng BC; Bezerra PP; Meng QR; Chin DW; Koh LB; Li H; Zhang H; Preiser PR; Boey FY; Venkatraman SS
Biointerphases; 2010 Sep; 5(3):FA53-62. PubMed ID: 21171714
[TBL] [Abstract][Full Text] [Related]
14. Heparin-functionalized chitosan-alginate scaffolds for controlled release of growth factor.
Ho YC; Mi FL; Sung HW; Kuo PL
Int J Pharm; 2009 Jul; 376(1-2):69-75. PubMed ID: 19450670
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic antithrombin blocks the heparan sulfate-dependent binding of proangiogenic growth factors to their endothelial cell receptors: evidence for differential binding of antiangiogenic and anticoagulant forms of antithrombin to proangiogenic heparan sulfate domains.
Zhang W; Swanson R; Xiong Y; Richard B; Olson ST
J Biol Chem; 2006 Dec; 281(49):37302-10. PubMed ID: 17040907
[TBL] [Abstract][Full Text] [Related]
16. Repifermin. Human Genome Sciences/GlaxoSmithKline.
Wheeler G
IDrugs; 2001 Jul; 4(7):813-9. PubMed ID: 15995938
[TBL] [Abstract][Full Text] [Related]
17. The covalently immobilized antimicrobial peptide LL37 acts as a VEGF mimic and stimulates endothelial cell proliferation.
Szulcek R; Bollensdorff C; Hordijk P; Gabriel M
Biochem Biophys Res Commun; 2018 Feb; 496(3):887-890. PubMed ID: 29366792
[TBL] [Abstract][Full Text] [Related]
18. Sustained release of human platelet lysate growth factors by thermosensitive hydroxybutyl chitosan hydrogel promotes skin wound healing in rats.
Lim T; Tang Q; Zhu Z; Wei X; Zhang C
J Biomed Mater Res A; 2020 Oct; 108(10):2111-2122. PubMed ID: 32323472
[TBL] [Abstract][Full Text] [Related]
19. Controlled delivery of the heparan sulfate/FGF-2 complex by a polyelectrolyte scaffold promotes maximal hMSC proliferation and differentiation.
Calarco A; Petillo O; Bosetti M; Torpedine A; Cannas M; Perrone L; Galderisi U; Melone MA; Peluso G
J Cell Biochem; 2010 Jul; 110(4):903-9. PubMed ID: 20564189
[TBL] [Abstract][Full Text] [Related]
20. Biomimetic proteoglycan nanoparticles for growth factor immobilization and delivery.
Zandi N; Mostafavi E; Shokrgozar MA; Tamjid E; Webster TJ; Annabi N; Simchi A
Biomater Sci; 2020 Feb; 8(4):1127-1136. PubMed ID: 31389409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
